Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2020 | 06-2020 | 04-2020 | 03-2020 | 07-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 90 | 90 | 43 |
| Other current assets | 0 | 0 | 1,724 | 1,724 | 1,458 |
| TOTAL | $0 | $N/A | $1,814 | $1,814 | $1,501 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $0 | $N/A | $1,814 | $1,814 | $1,501 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 930 | 930 | 1,105 |
| Other current liabilities | 0 | N/A | 63 | 63 | 79 |
| TOTAL | $0 | $N/A | $992 | $992 | $1,184 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $N/A | $992 | $992 | $1,184 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 7 | 7 | 6 |
| Retained earnings | 0 | N/A | -11,786 | -11,786 | -7,376 |
| Other shareholders' equity | 0 | 0 | -14,983 | -14,983 | -14,999 |
| TOTAL | $0 | $N/A | $822 | $822 | $317 |
| Total Liabilities And Equity | $0 | $0 | $1,814 | $1,814 | $1,501 |